WallStreetZenWallStreetZen

NASDAQ: LNTH
Lantheus Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lantheus Holdings earnings were $254.3M for the trailing 12 months ending Mar 31, 2025, with -45.5% growth year over year. The latest LNTH earnings report on Mar 31, 2025 announced Q1 2025 earnings of $72.9M, down 718.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LNTH reported annual earnings of $312.4M, with -4.4% growth. The next LNTH earnings date is Jul 31, 2025.

LNTH past earnings growth

How has LNTH's earnings growth performed historically?

Company
-45.55%
Industry
1.25%
Market
33.9%
LNTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LNTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LNTH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LNTH earnings history

Current Revenue
$1.5B
Current Earnings
$254.3M
Current Profit Margin
16.5%

LNTH Return on Equity

Current Company
22.8%
Current Industry
12.8%
Current Market
31.3%
LNTH's Return on Equity (22.8%)... subscribe to Premium to read more.
High Return on Equity Performance

LNTH undefined

Current Company
12.7%
Current Industry
6.9%
LNTH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LNTH announces earnings.

LNTH undefined

Current Company
20.8%
Current Industry
14.3%
LNTH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LNTH vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LNTH$438.66M$254.32M+42.71%$3.67
ALKS$463.88M$352.71M-17.94%$2.15
ELAN$1.40B$373.00MN/A$0.76
PBH$369.24M$214.61M+8.98%$4.32
PRGO$518.70M-$180.30MN/A-$1.31
View Top Pharmaceutical Stocks

LNTH earnings dates

Next earnings date
Jul 31, 2025

Lantheus Holdings Earnings Reports & History FAQ

What were Lantheus Holdings's earnings last quarter?

On LNTH's earnings call on Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q1 2025 earnings per share (EPS) of $1.06, up 44.5% year over year. Total LNTH earnings for the quarter were $72.95 million. In the same quarter last year, Lantheus Holdings's earnings per share (EPS) was $1.91.

If you're new to stock investing, here's how to buy Lantheus Holdings stock.

When does Lantheus Holdings report earnings?

The next LNTH earnings date is Invalid Date. Add LNTH to your watchlist to be reminded of Lantheus Holdings's next earnings date.

Is Lantheus Holdings profitable or losing money?

As of the last Lantheus Holdings earnings report, Lantheus Holdings is currently profitable. Lantheus Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $254.32 million, a 44.78% decrease year over year.

What was LNTH's earnings growth in the past year?

As of Lantheus Holdings's earnings date in Invalid Date, Lantheus Holdings's earnings has grown -45.55% year over year. This is 46.8 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 1.25%. LNTH earnings in the past year totalled $254.32 million.

What are Lantheus Holdings's earnings expectations?

The current EPS estimate for Lantheus Holdings's earnings report in Invalid Date is $1.69.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.